Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Strategic Asset Allocation Index
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Strategic Asset Allocation Index of 37.8% as of June 2023. Strategic assets (PP&E of CN¥2.11 Billion plus long-term investments of CN¥-) total CN¥2.11 Billion, measured against net assets of CN¥5.58 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Zhejiang Xianju Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Zhejiang Xianju Pharmaceutical Co Ltd Strategic Asset Allocation Index (2006–2021)
This chart shows how Zhejiang Xianju Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2006 to 2021. As of June 2023, the index stands at 37.8%, representing strategic assets of CN¥2.11 Billion against net assets of CN¥5.58 Billion CNY. For live market cap and overall valuation, see 002332 stock market capitalisation.
Annual Strategic Asset Allocation Index for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2021, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Zhejiang Xianju Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 40.7% | CN¥2.01 Billion | CN¥2.01 Billion | CN¥- | CN¥4.94 Billion | ▼ -1.3 pp |
| 2020 | 42.0% | CN¥1.93 Billion | CN¥1.93 Billion | CN¥- | CN¥4.58 Billion | ▼ -19.4 pp |
| 2019 | 61.5% | CN¥1.88 Billion | CN¥1.88 Billion | CN¥- | CN¥3.06 Billion | ▼ -5.3 pp |
| 2018 | 66.7% | CN¥1.81 Billion | CN¥1.62 Billion | CN¥186.05 Million | CN¥2.71 Billion | ▲ +3.1 pp |
| 2017 | 63.7% | CN¥1.52 Billion | CN¥1.36 Billion | CN¥155.99 Million | CN¥2.39 Billion | ▲ +2.9 pp |
| 2016 | 60.8% | CN¥1.36 Billion | CN¥1.20 Billion | CN¥161.85 Million | CN¥2.24 Billion | ▲ +1.9 pp |
| 2015 | 58.8% | CN¥1.27 Billion | CN¥1.09 Billion | CN¥175.46 Million | CN¥2.15 Billion | ▼ -28.6 pp |
| 2014 | 87.4% | CN¥1.07 Billion | CN¥1.07 Billion | CN¥- | CN¥1.23 Billion | ▼ -12.9 pp |
| 2013 | 100.4% | CN¥1.19 Billion | CN¥1.19 Billion | CN¥- | CN¥1.18 Billion | ▲ +16.2 pp |
| 2012 | 84.1% | CN¥1.01 Billion | CN¥1.01 Billion | CN¥- | CN¥1.20 Billion | ▲ +21.5 pp |
| 2011 | 62.6% | CN¥721.89 Million | CN¥721.89 Million | CN¥- | CN¥1.15 Billion | ▲ +28.7 pp |
| 2010 | 33.9% | CN¥380.09 Million | CN¥380.09 Million | CN¥- | CN¥1.12 Billion | ▲ +0.4 pp |
| 2009 | 33.5% | CN¥368.58 Million | CN¥368.58 Million | CN¥- | CN¥1.10 Billion | ▼ -44.6 pp |
| 2008 | 78.1% | CN¥316.82 Million | CN¥316.82 Million | CN¥- | CN¥405.55 Million | ▼ -3.7 pp |
| 2007 | 81.8% | CN¥328.01 Million | CN¥328.01 Million | CN¥- | CN¥400.83 Million | ▲ +5.8 pp |
| 2006 | 76.1% | CN¥297.44 Million | CN¥297.44 Million | CN¥- | CN¥390.97 Million | — |